Poor candidates for Tranont Activate People expecting prescription GLP-1 level weight loss results
This dual action has shown, in many clinical trials, to lead to even more significant weight loss and glycemic control for some individuals
Clinical studies consistently show substantial weight loss outcomes in patients using GLP-1 medications, often accompanied by improvements in blood sugar control, cholesterol levels, and decreased cardiovascular risks
Kirstie Canene-Adams Beyond ingredients, Ingredion provides formulation expertise spanning satiety and sensory science, regulatory compliance and texture optimization
Presented at American Diabetes Association 2026 Scientific Sessions, New Orleans
It does not mean this publication conducted laboratory testing, clinical evaluation, or independent medical assessment of any Omzo product or service